Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis

UnknownOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

March 21, 2020

Study Completion Date

October 21, 2020

Conditions
Renal FailureBacterial InfectionsCritical Illness
Interventions
DRUG

Ceftazidime-avibactam

Patients will be started on 2.5 gm IV every 8 hours

Trial Locations (1)

19140

RECRUITING

Temple University Hospital, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Temple University

OTHER